Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data was reported at 0.500 % in 2014. This stayed constant from the previous number of 0.500 % for 2013. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data is updated yearly, averaging 0.500 % from Dec 2008 (Median) to 2014, with 7 observations. The data reached an all-time high of 0.500 % in 2014 and a record low of 0.500 % in 2014. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.; ; UNAIDS estimates.; Weighted Average;
This data set includes tables on persons living with HIV/AIDS, newly diagnosed HIV cases and all cause deaths in HIV/AIDS cases by gender, age, race/ethnicity and transmission category. In all tables, cases are reported as of December 31 of the given year, as reported by January 9, 2019, to allow a minimum of 12 months reporting delay. Gender is determined by both current gender and sex at birth variables; transgender values are assigned when current gender is identified as "Transgender" or when a discrepancy is identified between a person's sex at birth and their current gender (e.g., cases where sex at birth is "Male" and current gender is "Female" will become Transgender: Male to Female.) Prior to 2003, Asian and Native Hawaiian/Pacific Islanders were classified as one combined group. In order to present these race/ethnicities separately, living cases recorded under this combined classification were split and redistributed according to their expected proportional population representation estimated from post-2003 data.
The following slide sets are available to download for presentational use:
New HIV diagnoses, AIDS and deaths are collected from HIV outpatient clinics, laboratories and other healthcare settings. Data relating to people living with HIV is collected from HIV outpatient clinics. Data relates to England, Wales, Northern Ireland and Scotland, unless stated.
HIV testing, pre-exposure prophylaxis, and post-exposure prophylaxis data relates to activity at sexual health services in England only.
View the pre-release access lists for these statistics.
Previous reports, data tables and slide sets are also available for:
Our statistical practice is regulated by the Office for Statistics Regulation (OSR). The OSR sets the standards of trustworthiness, quality and value in the https://code.statisticsauthority.gov.uk/" class="govuk-link">Code of Practice for Statistics that all producers of Official Statistics should adhere to.
Additional information on HIV surveillance can be found in the HIV Action Plan for England monitoring and evaluation framework reports. Other HIV in the UK reports published by Public Health England (PHE) are available online.
In the time of epidemics, what is the status of HIV AIDS across the world, where does each country stands, is it getting any better. The data set should be helpful to explore much more about above mentioned factors.
The data set contains data on
- No. of people living with HIV AIDS
- No. of deaths due to HIV AIDS
- No. of cases among adults (19-45)
- Prevention of mother-to-child transmission estimates
- ART (Anti Retro-viral Therapy) coverage among people living with HIV estimates
- ART (Anti Retro-viral Therapy) coverage among children estimates
https://github.com/imdevskp/hiv_aids_who_unesco_data_cleaning
Photo by Anna Shvets from Pexels https://www.pexels.com/photo/red-ribbon-on-white-surface-3900425/
- COVID-19 - https://www.kaggle.com/imdevskp/corona-virus-report
- MERS - https://www.kaggle.com/imdevskp/mers-outbreak-dataset-20122019
- Ebola Western Africa 2014 Outbreak - https://www.kaggle.com/imdevskp/ebola-outbreak-20142016-complete-dataset
- H1N1 | Swine Flu 2009 Pandemic Dataset - https://www.kaggle.com/imdevskp/h1n1-swine-flu-2009-pandemic-dataset
- SARS 2003 Pandemic - https://www.kaggle.com/imdevskp/sars-outbreak-2003-complete-dataset
- HIV AIDS - https://www.kaggle.com/imdevskp/hiv-aids-dataset
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
United States US: Incidence of HIV: per 1,000 Uninfected Population data was reported at 0.110 Ratio in 2019. This stayed constant from the previous number of 0.110 Ratio for 2018. United States US: Incidence of HIV: per 1,000 Uninfected Population data is updated yearly, averaging 0.120 Ratio from Dec 2010 (Median) to 2019, with 10 observations. The data reached an all-time high of 0.130 Ratio in 2012 and a record low of 0.110 Ratio in 2019. United States US: Incidence of HIV: per 1,000 Uninfected Population data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United States – Table US.World Bank.WDI: Social: Health Statistics. Number of new HIV infections among uninfected populations expressed per 1,000 uninfected population in the year before the period.;UNAIDS estimates.;Weighted average;This is the Sustainable Development Goal indicator 3.3.1 [https://unstats.un.org/sdgs/metadata/].
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Human Immunodeficiency Virus (HIV) remains a significant public health concern, with adults being at greater risk. Thus, understanding the dynamics of HIV transmission is crucial for effective prevention and control strategies, hence the need for a continuous clinical survey of the patients’ records of diagnosis and treatment for HIV. The data include the quarterly records of 138 adults diagnosed with HIV at Osun State University Teaching Hospital, Nigeria which involves the number of adults tested positive and negative for each of the endogenous variables discussed below. Information was sought using a convenient sampling method, which entails careful selection of individual records based on availability. The data was grouped into quarterly records of the diagnosed adults, with an average age ranging between 26 years and 52 years, and spread between the years 2008 and 2021. The records comprise 72 Females and 66 Males while the presence of each symptom is coded as 1 and the absence coded as 0. The endogenous variables observed in the clinical records of the surveyed patients are Fever (F), Diarrhea (D), Abdominal pain (AP), Skin rash (SR), Mouth sour (MS), Cellulitis (C), Coughing with sputum (CS), Loss of appetite (LA), Genital infections (GI), Medical fitness (MF), Headache (H), Catarrh (CA), Weight Loss (WL), Excessive Sweat (ES), Mouth Sour (MS), and Body weakness (BW). The impacts of these aforementioned factors would be examined on the spread of HIV. The clinical survey revealed that 77 individuals (55.80%) did not experience fever, while 61 (44.20%) did. Diarrhea was reported by 39 participants (28.26%), leaving 99 (71.74%) without this symptom. Abdominal pain and cellulitis were both reported by only 4 individuals (2.90%), with 134 participants (97.10%) indicating no occurrences of these symptoms. In terms of medical fitness, 110 individuals (79.71%) reported no fitness issues, whereas 28 (20.29%) reported having some. Cough with sputum affected 50 participants (36.23%), while 88 (63.77%) did not report this symptom. Headaches were almost universally absent, with 137 individuals (99.28%) not experiencing any. Catarrh was present in 14 participants (10.14%), with 124 (89.86%) reporting no instances. Loss of appetite was reported by 5 individuals (3.62%), and skin rashes were observed in 28 participants (20.29%). Weight loss affected 49 individuals (35.51%), and excessive sweating was reported by 137 participants (99.28%). Mouth soreness was noted in 27 participants (19.57%), while genital infections were reported by 6 individuals (4.35%). Body weakness was reported by 49 participants (35.51%). In the age distribution, 56 individuals (40.58%) fall into the young adult’s category while 82 individuals (59.42%) are categorized as older adults. Notably, all participants in the study were confirmed to be HIV positive, emphasizing a focused analysis of this group’s health characteristics.
Since the People Living with HIV Stigma Index was launched in 2008, shifts in the HIV epidemic, growth in the evidence base on how different populations are affected by stigma, and changes in the global response to HIV — particularly given the recommendation of early initiation of treatment — have highlighted the need to update and strengthen the Stigma Index as a measurement and advocacy tool. In October 2015, with support from USAID/PEPFAR, Project SOAR established a small working group (SWG) with representatives from the Global Network of People Living with HIV (GNP+), the International Community of Women Living with HIV (ICW), the Joint United Nations Programme on HIV/AIDS (UNAIDS), USAID, and several experts within and external to SOAR. The SWG outlined a process for evaluating and updating the Stigma Index that would be transparent and incorporate as many perspectives as possible in the process. The updated draft survey was then formally pilot-tested before being finalized and disseminated in late 2017.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
United States US: Incidence of HIV: % of Uninfected Population Aged 15-49 data was reported at 0.020 % in 2014. This stayed constant from the previous number of 0.020 % for 2013. United States US: Incidence of HIV: % of Uninfected Population Aged 15-49 data is updated yearly, averaging 0.030 % from Dec 2008 (Median) to 2014, with 7 observations. The data reached an all-time high of 0.030 % in 2012 and a record low of 0.020 % in 2014. United States US: Incidence of HIV: % of Uninfected Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Number of new HIV infections among uninfected populations ages 15-49 expressed per 100 uninfected population in the year before the period.; ; UNAIDS estimates.; Weighted Average;
The Find Ryan White HIV/AIDS Medical Care Providers tool is a locator that helps people living with HIV/AIDS access medical care and related services. Users can search for Ryan White-funded medical care providers near a specific complete address, city and state, state and county, or ZIP code. Search results are sorted by distance away and include the Ryan White HIV/AIDS facility name, address, approximate distance from the search point, telephone number, website address, and a link for driving directions. HRSA's Ryan White program funds an array of grants at the state and local levels in areas where most needed. These grants provide medical and support services to more than a half million people who otherwise would be unable to afford care.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Analysis of ‘HIV AIDS Dataset’ provided by Analyst-2 (analyst-2.ai), based on source dataset retrieved from https://www.kaggle.com/imdevskp/hiv-aids-dataset on 13 February 2022.
--- Dataset description provided by original source is as follows ---
In the time of epidemics, what is the status of HIV AIDS across the world, where does each country stands, is it getting any better. The data set should be helpful to explore much more about above mentioned factors.
The data set contains data on
- No. of people living with HIV AIDS
- No. of deaths due to HIV AIDS
- No. of cases among adults (19-45)
- Prevention of mother-to-child transmission estimates
- ART (Anti Retro-viral Therapy) coverage among people living with HIV estimates
- ART (Anti Retro-viral Therapy) coverage among children estimates
https://github.com/imdevskp/hiv_aids_who_unesco_data_cleaning
Photo by Anna Shvets from Pexels https://www.pexels.com/photo/red-ribbon-on-white-surface-3900425/
- COVID-19 - https://www.kaggle.com/imdevskp/corona-virus-report
- MERS - https://www.kaggle.com/imdevskp/mers-outbreak-dataset-20122019
- Ebola Western Africa 2014 Outbreak - https://www.kaggle.com/imdevskp/ebola-outbreak-20142016-complete-dataset
- H1N1 | Swine Flu 2009 Pandemic Dataset - https://www.kaggle.com/imdevskp/h1n1-swine-flu-2009-pandemic-dataset
- SARS 2003 Pandemic - https://www.kaggle.com/imdevskp/sars-outbreak-2003-complete-dataset
- HIV AIDS - https://www.kaggle.com/imdevskp/hiv-aids-dataset
--- Original source retains full ownership of the source dataset ---
The 2018 Nigeria AIDS Indicator and Impact Survey (NAIIS) is a cross-sectional survey that will assess the prevalence of key human immunodeficiency virus (HIV)-related health indicators. This survey is a two-stage cluster survey of 88,775 randomly-selected households in Nigeria, sampled from among 3,551 nationally-representative sample clusters. The survey is expected to include approximately 168,029 participants, ages 15-64 years and children, ages 0-14 years, from the selected household. The 2018 NAIIS will characterize HIV incidence, prevalence, viral load suppression, CD4 T-cell distribution, and risk behaviors in a household-based, nationally-representative sample of the population of Nigeria, and will describe uptake of key HIV prevention, care, and treatment services. The 2018 NAIIS will also estimate the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) infections, and HBV/HIV and HCV/HIV co-infections.
National coverage, the survey covered the Federal Republic and was undertaken in each state and the Federal Capital.
Household Health Survey
Sample survey data [ssd]
This cross-sectional, household-based survey uses a two-stage cluster sampling design (enumeration area followed by households). The target population is people 15-64 and children ages 0-14 years. The overall size and distribution of the sample is determined by analysis of existing estimates of national HIV incidence, sub-national HIV prevalence, and the number of HIV-positive cases needed to obtain estimates of VLS among adults 15-64 years for each of the 36 states and the FCT while not unnecessarily inflating the sample size needed.
From a sampling perspective, the three primary objectives of this proposal are based on competing demands, one focused on national incidence and the other on state-level estimates in a large number of states (37). Since the denominator used for estimating VLS is HIV-positive individuals, the required minimum number of blood draws in a stratum is inversely proportional to the expected HIV prevalence rate in that stratum. This objective requires a disproportionate amount of sample to be allocated to states with the lowest prevalence. A review of state-level prevalence estimates for sources in the last 3 to 5 years shows that state-level estimates are often divergent from one source to the next, making it difficult to ascertain the sample size needed to obtain the roughly 100 PLHIV needed to achieve a 95% confidence interval (CI) of +/- 10 for VLS estimates.
An equal-size approach is proposed with a sample size of 3,700 blood specimens in each state. Three-thousand seven hundred specimens will be sufficiently large to obtain robust estimates of HIV prevalence and VLS among HIV-infected individuals in most states. In states with a HIV prevalence above 2.5%, we can anticipate 95% CI of less than +/-10% and relative standard errors (RSEs) of less than 11% for estimates of VLS. In these states, with HIV prevalence above 2.5%, the anticipated 95% CI around prevalence is +/- 0.7% to a high of 1.1-1.3% in states with prevalence above 6%. In states with prevalence between 1.2 and 2.5% HIV prevalence estimates would remain robust with 95% CI of +/- 0.5-0.6% and RSE of less than 20% while 95% CI around VLS would range between 10-15% (and RSE below 15%). With this proposal only a few states, with HIV prevalence below 1.0%, would have less than robust estimates for VLS and HIV prevalence.
Face-to-face [f2f]
Three questionnaires were used for the 2018 NAIIS: Household Questionnaire, Adult Questionnaire, and Early Adolescent Questionnaire (10-14 Years).
During the household data collection, questionnaire and laboratory data were transmitted between tablets via Bluetooth connection. This facilitated synchronization of household rosters and ensured data collection for each participant followed the correct pathway. All field data collected in CSPro and the Laboratory Data Management System (LDMS) were transmitted to a central server using File Transfer Protocol Secure (FTPS) over a 4G or 3G telecommunication provider at least once a day. Questionnaire data cleaning was conducted using CSPro and SAS 9.4 (SAS Institute Inc., Cary, North Carolina, United States). Laboratory data were cleaned and merged with the final questionnaire database using unique specimen barcodes and study identification numbers.
A total of 101,267 households were selected, 89,345 were occupied and 83,909 completed the household interview . • For adults aged 15-64 years, interview response rate was 91.6% for women and 88.2% for men; blood draw response rate was 92.9% for women and 93.6% for men. • For adolescents aged 10-14 years, interview response rate was 86.8% for women and 86.2% for men; blood draw response rate was 91.2% for women and 92.3% for men. • For children aged 0-9 years, blood draw response rate was 68.5% for women and men.
Estimates from sample surveys are affected by two types of errors: non-sampling errors and sampling errors. Non-sampling errors result from mistakes made during data collection, e.g., misinterpretation of an HIV test result and data management errors such as transcription errors during data entry. While NAIIS implemented numerous quality assurance and control measures to minimize non-sampling errors, these were impossible to avoid and difficult to evaluate statistically. In contrast, sampling errors can be evaluated statistically. Sampling errors are a measure of the variability between all possible samples.
The sample of respondents selected for NAIIS was only one of many samples that could have been selected from the same population, using the same design and expected size. Each of these samples could yield results that differed somewhat from the results of the actual sample selected. Although the degree of variability cannot be known exactly, it can be estimated from the survey results. The standard error, which is the square root of the variance, is the usual measurement of sampling error for a statistic (e.g., proportion, mean, rate, count). In turn, the standard error can be used to calculate confidence intervals within which the true value for the population can reasonably be assumed to fall. For example, for any given statistic calculated from a sample survey, the value of that statistic will fall within a range of approximately plus or minus two times the standard error of that statistic in 95% of all possible samples of identical size and design.
NAIIS utilized a multi-stage stratified sample design, which required complex calculations to obtain sampling errors. The Taylor linearization method of variance estimation was used for survey estimates that are proportions, e.g., HIV prevalence. The Jackknife repeated replication method was used for variance estimation of more complex statistics such as rates, e.g., annual HIV incidence and counts such as the number of people living with HIV.
The Taylor linearization method treats any percentage or average as a ratio estimate, , where y represents the total sample value for variable y and x represents the total number of cases in the group or subgroup under consideration. The variance of r is computed using the formula given below, with the standard error being the square root of the variance: in which Where represents the stratum, which varies from 1 to H, is the total number of clusters selected in the hth stratum, is the sum of the weighted values of variable y in the ith cluster in the hth stratum, is the sum of the weighted number of cases in the ith cluster in the hth stratum and, f is the overall sampling fraction, which is so small that it is ignored.
In addition to the standard error, the design effect for each estimate is also calculated. The design effect is defined as the ratio of the standard error using the given sample design to the standard error that would result if a simple random sample had been used. A design effect of 1.0 indicates that the sample design is as efficient as a simple random sample, while a value greater than 1.0 indicates the increase in the sampling error due to the use of a more complex and less statistically efficient design. Confidence limits for the estimates, which are calculated as where t(0.975, K) is the 97.5th percentile of a t-distribution with K degrees of freedom, are also computed.
Remote data quality check was carried out using data editor
The Philippines reported about ****** HIV cases, an increase from the previous year. The number of reported HIV cases has gradually increased since 2012, aside from a significant dip in 2020. The state of HIV As the monthly average number of people newly diagnosed with HIV increases, the risk it poses threatens the lives of Filipinos. HIV is a sexually transmitted infection that attacks the body’s immune system, with more males being diagnosed than females. In 2022, the majority of people newly diagnosed with HIV were those between the age of 25 and 34 years, followed by those aged 15 and 24. There is still no cure for HIV and without treatment, it could lead to other severe illnesses such as tuberculosis and cancers such as lymphoma and Kaposi’s sarcoma. However, HIV is now a manageable chronic illness that can be treated with proper medication. What are the leading causes of death in the Philippines? Between January and September 2024, preliminary figures have shown that ischaemic heart disease was the leading cause of death in the Philippines. The prevalence of heart diseases in the nation has been closely attributed to the Filipino diet, which was described as having a high fat, high cholesterol, and high sodium content. In addition, acute respiratory infections and hypertension also registered the highest morbidity rate among leading diseases in the country in 2021.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Because of the small populations of American Indian/Alaska Native populations in the cities, they are grouped with multiple races/other.Because of small populations of Native Hawaiians and other Pacific Islanders they are grouped with multiple races/other.
Ratio: Weighted number of survey respondents who reported being tested for HIV in the past 12 months.
Definition: Proportion of adults aged 18-64 years who have been tested for HIV in the past 12 months.
Data Source: Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health
The Sexually Transmitted Disease (STD) Morbidity online databases on CDC WONDER contain case reports reported from the 50 United States and D.C., Puerto Rico, Virgin Islands and Guam. The online databases report the number of cases and disease incidence rates by year, state, disease, age, sex of patient, type of STD, and area of report. Data are produced by the U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, viral Hepatitis, STD and TB Prevention (NCHHSTP).
Rate: HIV-infected adolescents and adults who receive HIV care and treatment consistent with current standards, per 100,000 HIV-infected persons age 13+.
Definition: Percent of HIV-infected adolescents and adults who receive HIV care and treatment consistent with current standards.
Data Sources: Division of HIV/AIDS, STD, and TB Services, New Jersey Department of Health
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AimsTwo behavioral HIV prevention interventions for people who inject drugs (PWID) infected with HIV include the Holistic Health Recovery Program for HIV+ (HHRP+), a comprehensive evidence-based CDC-supported program, and an abbreviated Holistic Health for HIV (3H+) Program, an adapted HHRP+ version in treatment settings. We compared the projected health benefits and cost-effectiveness of both programs, in addition to opioid substitution therapy (OST), to the status quo in the U.S.MethodsA dynamic HIV transmission model calibrated to epidemic data of current US populations was created. Projected outcomes include future HIV incidence, HIV prevalence, and quality-adjusted life years (QALYs) gained under alternative strategies. Total medical costs were estimated to compare the cost-effectiveness of each strategy.ResultsOver 10 years, expanding HHRP+ access to 80% of PWID could avert up to 29,000 HIV infections, or 6% of the projected total, at a cost of $7,777/QALY gained. Alternatively, 3H+ could avert 19,000 infections, but is slightly more cost-effective ($7,707/QALY), and remains so under widely varying effectiveness and cost assumptions. Nearly two-thirds of infections averted with either program are among non-PWIDs, due to reduced sexual transmission from PWID to their partners. Expanding these programs with broader OST coverage could avert up to 74,000 HIV infections over 10 years and reduce HIV prevalence from 16.5% to 14.1%, but is substantially more expensive than HHRP+ or 3H+ alone.ConclusionsBoth behavioral interventions were effective and cost-effective at reducing HIV incidence among both PWID and the general adult population; however, 3H+, the economical HHRP+ version, was slightly more cost-effective than HHRP+.
Streamlining dietary and nutrition-specific counseling especially among malnutrition vulnerable HIV positive patients requires provision of targeted-specific information based on regional differences and socio-economic variations. This assessment seeks to understand the variations in dietary patterns of people living with HIV (PLHIV) who access HIV care services at the 11 different USAID/SUSTAIN supported Regional Referral Hospitals (RRH) in Uganda. It also provides information on the relationship between dietary diversity and socio-demographic, economic and HIV care related factors among PLHIV. The findings shall as well provide various stakeholders involved in HIV/AIDS programming care and policy makers with additional information to enable design of appropriate nutritional interventions to improve HIV nutritional care programs particularly among adults. This was a retrospective unmatched case control study, which targeted 583 (147 cases and 436 controls) HIV infected individuals attending HIV clinics at eleven USAID/SUSTAIN supported Ugandan RRH. The specific objectives were 1. To identify the foods commonly consumed by PLHIV attending HIV clinics at RRH in Uganda. 2. To compare dietary patterns of malnourished and non-malnourished HIV patients attending HIV clinics at RRH in Uganda. 3. To explore demographic, socio-economic and hospital care factors associated with dietary patterns among HIV patients attending HIV clinics at RRH in Uganda. 4. To identify and compare coping mechanisms during food scarcity between the malnourished and non-malnourished HIV patients attending HIV clinics at RRH in Uganda.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
This dataset is about countries per year in South America. It has 768 rows. It features 4 columns: country, urban population living in areas where elevation is below 5 meters , and incidence of HIV.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
aIncludes cases of HIV infection, newly diagnosed in Australia in 2010 and reported by 31 March 2012. The exposure category “Heterosexual contact” includes cases from high prevalence countries in sub-Saharan Africa and specific countries in South East Asia (Burma, Cambodia).bDataset is not nationally representative; it includes data from 5 of the 13 provinces and territories. Across all 13 provinces and territories, a total of 2,358 HIV cases were reported in 2010. The case definition for AIDS in Canada is based on confirmed HIV diagnosis and presence/diagnosis of an AIDS-defining condition (no criteria for CD4 count are included in Canada’s AIDS case definition).cData for the whole country, adjusted for under-reporting and reporting delays. Missing data on age,sex, transmission category and clinical stage are imputed. Data reported as of 30 June, 2011. MSM-IDU are in “others”.dIn 2010 the coverage of HIV surveillance system is 97.8%. AIDS is undereported. AIDS defined as clinical stage C (CDC classification).eIncludes cases of HIV infection, newly diagnosed in the United States in 2010 and reported by 31 December 2011. Estimated numbers resulted from statistical adjustment that accounted for missing risk-factor information, but not for reporting delays and incomplete reporting.fMSM, men who have sex with men; IDU, injection drug use.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data was reported at 0.500 % in 2014. This stayed constant from the previous number of 0.500 % for 2013. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data is updated yearly, averaging 0.500 % from Dec 2008 (Median) to 2014, with 7 observations. The data reached an all-time high of 0.500 % in 2014 and a record low of 0.500 % in 2014. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.; ; UNAIDS estimates.; Weighted Average;